comparemela.com

Latest Breaking News On - Centre liberalised pricing - Page 1 : comparemela.com

Prioritise vaccine supply to States from non-governmental quota: Kerala High Court

Updated: Court asks Centre how private hospitals are getting vaccines when State’s requests are pending Share Article AAA Kerala High Court has observed that there should be some yardstick in the supply of COVID-19 vaccines from the non-governmental quota.   | Photo Credit: K.K. Mustafah Court asks Centre how private hospitals are getting vaccines when State’s requests are pending A Division Bench of the Kerala High Court on Wednesday orally observed that the request of the State governments for vaccine supply from non-governmental quota should be prioritised. The Bench comprising Justice A. Muhamed Mustaque and Justice Kauser Edappagath orally observed that the request of the State government should be considered on a par with the request of the private hospitals and other private entities. There should be some yardstick for supply of vaccines under the non-governmental quota.

Kerala HC for prioritising the government request for Covid vaccines from non-governmental quota

Why don t utilise the surplus RBI dividend for free vaccination: Kerala HC asks Centre

May 24, 2021 The State had already placed a purchase order for 1 crore doses of Covid vaccine A Division Bench of the Kerala High Court on Monday asked the Centre to inform the court when it could supply the Covid vaccines ordered by the State government. When a petition challenging the Centre s Liberalised Pricing and Accelerated National Covid-19 Vaccination Strategy and other Covid vaccination related cases came up for hearing, the Bench asked the Centre what was the rationale behind its stand that the State should administer the vaccines free of cost to the people in the age group of 18 to 44 on its own, especially when the Centre did not supply the vaccines for these group free of cost. The court also reminded the Centre that it was not time to talk about federalism.

Out of Covaxin, Delhi govt urges Serum Institute to come to rescue & provide Covishield

After Bharat Biotech said it cannot supply more doses of Covaxin to Delhi, the city government wrote to the Serum Institute of India (SII) asking it to come to its rescue , saying it has limited stock of Covishield for 18 to 44 years which will finish in one week. To this, the SII said they are doing their best to meet countrywide vaccine requirements, official sources said. In a letter to the SII, Director of Family Welfare, Delhi Government, Dr Monika Rana said, We rely on your support for provision of sufficient quantities of vaccine in a time-bound manner. Delhi has a limited stock of Covishield for 18 to 44 years which will finish in one week and vaccination centres will have to be closed due to non-availability of vaccines, she said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.